Browse drugs

…ies (e.g. adoptive cell transfer, immune checkpoint inhibitors, oncolytic virus...) in oncology.Results Growth characteristics of human tumors …

…types were urothelial (n=307; 53.9%) and breast (n=125; 21.9%). Pembrolizumab (n=386; 67.7%) and enfortumab vedotin (n=291; 51.1%) were the m…

… analyzed to identify immune-modulatory factors associated with cisplatin (DDP) resistance. The effects of DDP on Galectin-9 (Gal-9) expr…

… was used to assess anti-tumor efficacy of anti-hCD47 antibody (Magrolimab (5F9)) in a CT26-hCD47 (CT26 cells overexpressing human CD47) c…

…ng of brain metastases in relation to outcome during first-line ipilimumab plus nivolumab therapy for metastatic melanoma in a community o…

…ycles of administration of a dual inhibitor of PD-L1 and TGF-β, bintrafusp alfa, in 51 patients with HPV16/18-associated cancers ( NCT03427411)…

…ogous or allogeneic immune cells (PBMCs, TILs) and treated with ICIs—alone or combined with drugs identified via in silico modeling …

…(11):2835–2843. doi: 10.1038/s41591-023-02583-2.Luke JJ, et al, Pembrolizumab versus placebo as adjuvant therapy in completely resected stage…

…al prognosis and urgently require effective salvage treatments. iNeo-Vac-R01, a novel personalized neoantigen-based mRNA cancer vaccine, was…

…tic ccRCC.Methods Fifteen patients received escalating doses of ERVE-4 T-cells (1, 5, 10, and 50 x 10^6 cells/kg) in a 3+3 design. TCR…

…Background Single-agent immune checkpoint inhibitors (ICI) is the standard treatment for patients with metastatic non-sma…

…ze the TCR sequence associated with the efficacy of neoadjuvant nivolumab and confirm their belonging T cell subsets.Results Among them, …